Multiple sclerosis (MS) is an autoimmune inflammatory disease of the central nervous system (CNS) that has long been associated with stress and the sympathoadrenergic response 1,2 . The sympathetic hormone norepinephrine (NE), a major mediator of the response to physiological and psychological stressors, has been shown to be involved in the pathology of experimental autoimmune encephalitis (EAE), the rodent model of MS [3] [4] [5] [6] . However, the molecular mechanisms that link stress signaling to neuroinflammation remain unclear.
Multiple sclerosis (MS) is an autoimmune inflammatory disease of the central nervous system (CNS) that has long been associated with stress and the sympathoadrenergic response 1, 2 . The sympathetic hormone norepinephrine (NE), a major mediator of the response to physiological and psychological stressors, has been shown to be involved in the pathology of experimental autoimmune encephalitis (EAE), the rodent model of MS [3] [4] [5] [6] . However, the molecular mechanisms that link stress signaling to neuroinflammation remain unclear.
The Nr4a orphan nuclear receptors Nr4a1 (Nur77), Nr4a2 (Nurr1) and Nr4a3 (Nor1) are encoded by early-immediate response genes rapidly induced by a variety of physiological stimuli 7 . Nr4a1, like other members of the Nr4a family, is involved in early sympathetic stress response in the neuroendocrine system [8] [9] [10] [11] . At the same time, Nr4a1 has an important role in leukocytes, in which it is a central regulator of innate and adaptive immune responses. As such, Nr4a1 is involved in the activation and differentiation of macrophages in atherosclerosis 12, 13 and also controls the differentiation and survival of nonclassical Ly6C − patrolling monocytes 14, 15 . Furthermore, Nr4a1 is rapidly induced in T cells following activation of the T cell antigen receptor and reflects the strength of signaling via this receptor 16 . Thus, Nr4a1 is involved both in immunity and in the stress response and it might therefore represent a key junction in the crosstalk between the sympathetic nervous system and immune system, particularly in the context of neuroinflammation.
To test that hypothesis, we used an established model of EAE and found that mice lacking Nr4a1 developed accelerated and exacerbated disease that was accompanied by high concentrations of NE and interleukin 6 (IL-6) and early auto-aggressive infiltration of T cells into the CNS. Mechanistically, we discovered that Nr4a1 inhibited macrophage expression of tyrosine hydroxylase (TH), the rate-limiting enzyme for NE production 17 . We found that myeloid-specific deletion of TH protected mice from EAE. Our data demonstrate a major role for the production of NE by macrophages in neuroinflammation and identify an important mechanism for the regulation of NE by Nr4a1.
RESULTS

Nr4a1 expression in myeloid cells limits EAE severity
To determine if Nr4a1 has a role in CNS autoimmunity, we analyzed Nr4a1 expression in mice during EAE. We used a passive model of EAE (Supplementary Fig. 1a ) that involves the in vitro differentiation of autoreactive CD4 + T lymphocytes from 2D2 mice (which have transgenic expression of a T cell antigen receptor specific for a myelin oligodendrocyte glycoprotein peptide of amino acids 18 into the T H 1 subset of helper T cells, followed by adoptive transfer of the cells into host mice (Supplementary Fig. 1b) . To address Nr4a1 expression during EAE at the cellular level, we induced the disease in mice expressing green fluorescent protein (GFP) under control of the Nr4a1 promoter (Nr4a1-GFP) 16 . By intravital microscopy, we observed significant induction of Nr4a1-GFP expression in the spinal cord at the onset of EAE (Fig. 1a) . To determine the identity of the cells expressing Nr4a1-GFP, we used flow cytometry. We identified microglia as CD45 lo CD11b + cells 19 , whereas the phenotype CD45 hi CD11b + identified infiltrating myeloid cells (Fig. 1b) . We further gated CD45 hi CD11b + infiltrating myeloid populations to distinguish among granulocytes (Ly6G + MHCII − ), monocytes (Ly6G − MHCII − ) and macrophages (Ly6G − MHCII + ) (Fig. 1b) . Macrophages identified by flow cytometry in the CNS were also positive for the core tissue macrophage marker CD64 and the receptor MerTK 20 , while monocytes characteristically expressed some CD64 but not MerTK 21 (Supplementary Fig. 1c ). Nr4a1-GFP had high expression in infiltrating macrophages and, to a lesser extent in infiltrating monocytes, and in resident microglia (Fig. 1b) . Nr4a1 expression was relatively low in granulocytes and other infiltrating cells (which were probably non-2D2 lymphocytes) (Fig. 1b) .
To address the importance of Nr4a1 expression in CNS autoimmunity, we induced EAE in Nr4a1 −/− mice 22 . This resulted in much earlier onset and exacerbated disease development ( Fig. 2a and Supplementary Fig. 2a,b) , as well as accelerated body mass loss (Supplementary Fig. 2c ), compared with that of wild-type mice. Nr4a1 −/− mice were also more susceptible than wild-type mice to EAE induced by active immunization with myelin oligodendrocyte glycoprotein peptide (amino acids (Supplementary Fig. 2d ).
Nr4a1 had high expression in myeloid cells in the CNS at the onset of EAE (Fig. 1) . Therefore, to address the role of Nr4a1 in myeloid cells, we used mice with specific deletion of loxP-flanked Nr4a1 alleles (Nr4a1 fl/fl ) by Cre recombinase expressed from either of two well-characterized myeloid-specific transgenes, LysM-Cre (Nr4a1 ∆LysM ) or Csf1r-Cre (Nr4a1 ∆Csf1r ). We first analyzed the expression of Nr4a1 mRNA and deletion efficacy in the myeloid cells in these strains. In Nr4a1 fl/fl mice negative for the Cre-encoding transgenes, Nr4a1 mRNA had its highest expression in monocytes and macrophages, with lower expression in granulocytes and microglia (Fig. 2b) . Expression of LysM-Cre significantly reduced the expression of Nr4a1 mRNA in macrophages, monocytes and granulocytes but not in microglia, while expression of Csf1r-Cre effectively reduced the expression of Nr4a1 mRNA in all myeloid populations (Fig. 2b) . Mice with myeloid-specific deletion of Nr4a1 achieved via either LysM-Cre or Csfr1-Cre developed substantially exacerbated EAE compared with that of their Nr4a1 fl/fl (control) littermates (Fig. 2c,d and Supplementary Fig. 2e ). To assess the possibility of a role of Nr4a1 in T cells in EAE onset, we transferred Nr4a1 −/− 2D2 autoimmune T cells into wild-type mice. In contrast to the myeloid deletion of Nr4a1, T cell-specific loss of Nr4a1 had no effect on disease outcome (Supplementary Fig. 2f ). Collectively, these data suggested that Nr4a1 expression in infiltrating monocytes and monocyte-derived macrophages might serve a protective role in EAE.
To further characterize the phenotype of Nr4a1 −/− mice, we sought to determine the identity of inflammatory cells in their CNS by flow cytometry. To track myeloid cells in vivo, we used Nr4a1 +/+ and Nr4a1 −/− mice expressing a CX3CR1-GFP reporter, in which a GFP-encoding sequence is knocked into one allele of the gene encoding the chemokine receptor CX3CR1, a marker of macrophages and microglia [23] [24] [25] [26] . In this setting, microglia were characteristically CD45 lo CX3CR1-GFP hi , while infiltrating monocytes-macrophages were CD45 hi CX3CR1-GFP lo CD11b hi (Fig. 2e) . To track CNS-infiltrating 2D2 T cells, we used 2D2 cells expressing the red fluorescent protein DsRed 27 for injection into recipient mice. The majority (68%) of the inflammatory CNS infiltrate in wild-type mice was 2D2 cells, while 24% of the infiltrate was infiltrating CD11b hi myeloid cells (Fig. 2e) . The infiltration of total leukocytes (all CD45 + ) and specifically 2D2 T cells was about sixfold higher in Nr4a1 −/− mice than in Nr4a1 +/+ mice (Fig. 2e) . Among the infiltrating myeloid cells, macrophages represented the main cell population (~80%), and their numbers were significantly greater in Nr4a1 −/− mice than in Nr4a1 +/+ mice (Fig. 2e) .
The number of infiltrating monocytes was also greater in Nr4a1 −/− mice than in Nr4a1 +/+ mice (Supplementary Fig. 3a) . Most of the infiltrating monocytes in both strains were inflammatory Ly6C + monocytes (Supplementary Fig. 3a) . Non-classical Ly6C − monocytes A r t i c l e s represented only a minor fraction in Nr4a1 +/+ mice and were almost completely absent in Nr4a1 −/− mice (Fig. 2e) , in line with the reported role of Nr4a1 in the differentiation of Ly6C − monocytes 15 . Studies have shown that in EAE, Ly6C + inflammatory monocytes are recruited to the CNS and give rise to macrophages, and that infiltrating Ly6C + monocyte and monocyte-derived macrophage populations are critical for EAE development 23, [28] [29] [30] . Analysis of monocytes isolated from the CNS of Nr4a1-GFP mice showed that Nr4a1 had its highest expression in Ly6C − monocytes but was also expressed in Ly6C + monocytes during disease (Supplementary Fig. 3b ), which suggested an important role for Nr4a1 in regulating these cell types in EAE. By intravital microscopy, we confirmed earlier infiltration of leukocytes and more-severe CNS damage in Nr4a1 −/− mice than in Nr4a1 +/+ mice. At 4 d after T cell transfer, few pioneering DsRed + 2D2 T cells were infiltrating the nervous tissue of the thoracic spinal cord segment in both Nr4a1 +/+ mice and Nr4a1 −/− mice ( Fig. 2f and Supplementary   Fig. 4a ). In contrast, at day 7, we found substantial infiltration of DsRed + 2D2 T cells into Nr4a1 −/− spinal cords, whereas in Nr4a1 +/+ mice, the infiltration of 2D2 cells remained confined to an area near the posterior spinal vein (Fig. 2f, Supplementary Fig. 4b and Supplementary Movies 1 and 2). Vascular permeability in brain was similar in wild-type mice and Nr4a1 −/− mice ( Supplementary Fig. 4c ), which indicated that the increase in the infiltration of T cells in the Nr4a1 −/− mice was not caused by impaired function of the blood-brain barrier.
Microglial activation is associated with morphological changes of the cell body and loss of dendritic 'ramified' projections seen in the homeostatic state 31 . Consistent with that, at day 7 after T cell transfer, ramified microglia were much less abundant and rounded microglia were more abundant in Nr4a1 −/− mice than in Nr4a1 +/+ mice in the spinal cord ( Fig. 2f and Supplementary Fig. 5a ) and brain ( Supplementary Fig. 6 ). Flow cytometry analyzing CD44 and major histocompatibility complex (MHC) class II, markers of activated microglia, further confirmed early microglia activation in Nr4a1 −/− mice ( Supplementary Fig. 5b,c) . Notably, we also found that at day 7, Nr4a1 −/− mice had higher blood concentrations of NE, IL-6 and the IL-6-associated chemokine CXCL1 than did wild-type mice (Fig. 2g) . Together these data showed that Nr4a1 −/− mice developed early and exacerbated EAE, which involved greater induction of NE and IL-6 in blood, accelerated recruitment of autoreactive T cells to the CNS, and early activation of microglia. Given the higher concentration of NE in Nr4a1 −/− mice upon the induction of EAE, we hypothesized that Nr4a1 −/− mice had higher expression of TH in their spinal cord than did wild-type mice early in EAE development. To exclude the possibility of changes resulting from the more-advanced disease stage in Nr4a1 −/− mice, we compared wild-type mice and Nr4a1 −/− mice with the same disease score. As we expected, in the early stages of EAE and even before disease induction, Nr4a1 −/− mice showed a greater abundance of mRNA encoding TH, IL-6 and the IL-6-induced chemokines CCL5 and CXCL1 (Fig. 2h) . This finding was consistent with a published report showing higher TH expression in the CNS of Nr4a1 −/− mice 32 . Our data therefore suggested that Nr4a1 regulated the production of NE and IL-6 and thereby limited susceptibility to EAE.
Essential role for NE-producing myeloid cells in EAE To investigate whether excessive production of NE contributed to the EAE severity of Nr4a1 −/− mice, we applied adrenergic inhibitors that block autocrine and paracrine NE signaling. Blockade of α1 adrenergic receptors significantly reduced EAE progression in Nr4a1 −/− mice (Fig. 3a) , but blockade of β1 or β2 adrenergic receptors did not (Supplementary Fig. 7a,b) . Depleting mice of catecholamines through use of the noradrenergic neurotoxin 6-OHDA (6-hydroxydopamine) also inhibited the progression of EAE in both wild-type mice and Nr4a1 −/− mice (Fig. 3b) ; this highlighted the critical role of catecholamines in the development of EAE.
To identify the cellular source of NE in EAE, we isolated cells from the CNS of mice with EAE and used flow cytometry to analyze their expression of TH. Notably, we found that TH expression increased with disease progression in macrophages and, to a lesser extent, in monocytes and microglia, but not in granulocytes (Fig. 3c) . As macrophages represented a principal component of the CNS infiltrate, these results indicated that TH + macrophages recruited to the CNS might be a major driving force behind the development of EAE.
To test that possibility, we used DDfs ('dopamine-deficient floxed stop') mice, which have a non-functional gene encoding TH 33 and in which TH expression was much lower than that of mice with a wildtype gene encoding TH (Supplementary Fig. 7c ). Wild-type mice given transplantation of DDfs bone marrow were protected from EAE development (Fig. 3d) . To further substantiate the role of myeloid TH in driving EAE, we used mice with selective deletion of the gene encoding TH in LysM + myeloid cells. These mice had lower TH expression in CNS-infiltrating myeloid cells, but not in microglia or other leukocytes, than that of wild-type mice (Supplementary Fig. 7d) , and also showed lower concentrations of NE in blood ( Supplementary  Fig. 7e ). These mice with myeloid-specific deletion of Th were protected from the progression of EAE disease (Fig. 3e) . The findings that TH expression in granulocytes did not change with disease progression and that LysM-Cre-driven deletion of Th, as well as transfer of DDfs bone marrow, reduced EAE severity while allowing retention of microglial TH expression, further suggested that TH-expressing 
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infiltrating monocytes and monocyte-derived macrophages were the cells important for EAE development. Mechanistically, we hypothesized that NE secreted from macrophages during EAE might activate them in an autocrine manner and thereby amplify the neuro-inflammatory cascade, which would lead to the recruitment of T cells to the CNS. To test this hypothesis, we used bone marrow-derived macrophages (BMMs) as a model of monocytederived macrophages, since these cells have been shown to both produce NE 34 and express adrenergic receptors 35 . BMMs treated with NE upregulated Il6, and this upregulation was abolished by the α1-adrenergic blocker and, to a lesser extent, by the β1-adrenergic blocker (Fig. 3f) ; this suggested that the macrophages were able to sense NE and produce IL-6 in response. Il6 expression was also reduced by the TH inhibitor AMPT (α-methyl-p-tyrosine) in BMMs treated with interferon-γ (IFN-γ) (Fig. 3f) . Upon stimulation with IFN-γ, BMMs from DDfs mice showed much lower expression of Il6 and genes encoding IL-6-driven chemokines than did wild-type BMMs (Fig. 3g) , which further confirmed the hypothesis of a role for autocrine catecholamine production in macrophage neuroinflammatory signaling. Collectively, these results suggested that in early stages of EAE, monocytes and macrophages had increased TH activity and secreted NE, which resulted in the production of IL-6 and IL-6-associated chemokines and thus drove the recruitment of leukocytes to the CNS.
Negative regulation of TH by Nr4a1 in macrophages
Given the essential role of macrophage TH in EAE and our observation that the susceptibility of Nr4a1 −/− mice to EAE was accompanied by higher TH expression, we sought to determine whether Nr4a1 had a relevant role in the regulation of TH in macrophages. Similar to the high Nr4a1 expression in vivo in macrophages during neuroinflammation, the expression of both Nr4a1 mRNA and Nr4a1-GFP was higher in BMMs stimulated with either IFN-γ or NE than in unstimulated BMMs (Supplementary Fig. 8a-c) ; this suggested a role for Nr4a1 as a sensor of both sympathetic stress and inflammatory stress in macrophages. We therefore sought to determine if Nr4a1 might directly regulate the expression of TH in macrophages as a feedback regulation mechanism. BMMs from Nr4a1 −/− mice showed much higher expression of Th mRNA (Fig. 4a) and TH protein (Fig. 4b) at baseline and after treatment with IFN-γ than did wild-type BMMs. Nr4a1 −/− macrophages also secreted significantly more NE than did wild-type BMMs ( Supplementary  Fig. 8d ), and this effect was inhibited by the TH inhibitor AMPT and by 6-OHDA (Supplementary Fig. 8d ). Therefore, a lack of Nr4a1 increased TH expression and NE production in macrophages.
To elucidate the molecular mechanism for the regulation of TH by Nr4a1, we used the mouse macrophage cell line RAW264.7 (RAW), as these cells have been shown to both produce NE and sense NE 36 . Overexpression of Nr4a1 in RAW cells downregulated the expression of Th mRNA and, conversely, knockdown of Nr4a1 upregulated the expression of Th mRNA (Fig. 4c) . Moreover, loss of Nr4a1 led to increased activity of a 4.5-kilobase fragment of the mouse Th promoter in both BMMs and RAW cells, as assessed by a promoter-reporter assay (Supplementary Fig. 8e ). This suggested that Nr4a1 repressed the transcription of Th. Collectively, these data identified Nr4a1 as an important negative regulator of TH expression in macrophages.
Another member of the Nr4a family, Nr4a2, has been shown to bind to the Th promoter in developing neurons 37, 38 and to downregulate Th expression by recruiting the co-repressor CoREST 39 . CoREST is known to suppress the transcription of neuron-specific genes in a complex with histone deacetylase 40, 41 . Nr4a1 has also been shown to suppress transcription by recruiting the CoREST complex 42, 43 . Because Nr4a1 and Nr4a2 share the same minimal DNA-binding sequence 7 , we hypothesized that Nr4a1 might also downregulate Th transcription by recruiting the CoREST complex.
Knockdown of CoREST with small interfering RNA significantly increased Th mRNA expression in RAW cells (Fig. 4c) . Furthermore, we were able to detect direct interaction between Nr4a1 and CoREST in RAW cells by co-immunoprecipitation (Fig. 4d) and also detected Nr4a1-dependent binding of CoREST to the reported Nr4a-binding sites in the Th promoter 37 through the use of chromatin immunoprecipitation (Fig. 4e) . Chromatin immunoprecipitation analysis also showed increased abundance of acetylated histone H3 at the Th promoter after knockdown of Nr4a1 and, to a greater extent, after knockdown of CoREST (Fig. 4e) , which confirmed our hypothesis that CoREST regulates Th transcription by recruiting histone deacetylase. Together these results suggested that Nr4a1 directly suppressed the transcription of Th in macrophages by recruiting the CoREST complex to the Th promoter. 
npg
Higher expression of TH in monocytes of patients with MS Published studies have shown that CNS-infiltrating monocytes and monocyte-derived macrophages are crucial for the pathogenesis of EAE 23, [28] [29] [30] . Our data indicated that monocytes and macrophages isolated from CNS during EAE had high expression of TH and that myeloid TH expression was important for the development of EAE. TH expression in human and mouse monocyte-derived macrophages has been reported 34, 44, 45 , but its importance in neuroinflammation was not studied. To address the relevance of TH-expressing monocytes and macrophages to human MS, we analyzed peripheral blood mononuclear cells obtained from patients with MS and age-and sex-matched healthy donors (Fig. 5a ). We were able to detect TH in both monocytes and lymphocytes in all samples; however, TH expression was higher in monocytes than in all other circulating cells (Fig. 5b) . In support of our mouse data, patients with MS exhibited higher TH expression in CD14 + monocytes than did healthy control subjects (Fig. 5c) . As classical monocytes differentiate into macrophages once they infiltrate the CNS during the onset of EAE 23, 28, 30 , these data suggested that TH-expressing monocytes and monocyte-derived macrophages might also have a role in human MS.
DISCUSSION
The main objective of this study was to identify functional and regulatory mechanisms that link stress signaling and neuroinflammation. Adrenergic signaling has long been associated with EAE; however, a role for NE-producing macrophages has not been suggested. A series of publications has shown that prazosin, an α-adrenergic blocker, has a protective effect in both active EAE models and passive EAE models in Lewis rats 4, 5, 46, 47 , in agreement with our work. Those authors suggested that prazosin might exert its effect by stabilizing the blood-brain barrier; however, since vascular leakage correlated with the EAE score in both control (untreated) rats and treated rats 46, 47 , the decreased leakage through the blood-brain barrier might have been secondary to the overall disease suppression by prazosin. We found no gross changes in vascular permeability in Nr4a1 −/− mice; thus, the protective role of Nr4a1 in EAE could not be attributed to such changes. Nevertheless, effects of adrenergic signaling on vascular endothelial cells might indeed serve a role in EAE, such as by inducing IL-6 production and facilitating the recruitment of leukocytes to CNS 3 . Moreover, our findings indicated that monocytes and macrophages might be a major source of NE for triggering this endothelial activation cascade, in addition to the autocrine signaling we have described.
The main myeloid populations isolated from CNS during EAE included infiltrating monocytes, monocyte-derived macrophages, microglia and granulocytes. Published studies have shown that recruited monocyte-derived macrophages are critical for the development of EAE 23, [28] [29] [30] . Macrophages have been shown to express TH and produce catecholamines in mice and humans 34, 36, 44, 45, 48 . In line with those reports, we found a disease-promoting role for TH in recruited macrophages and identified a previously unknown mechanism of neuroprotection by Nr4a1-mediated repression of TH. We observed high expression of Nr4a1 and TH in both infiltrating monocytes and monocyte-derived macrophages and, to a lesser extent, in microglia. There was relatively low expression of both Nr4a1 and TH in granulocytes, which diminished the possibility of Nr4a1-mediated regulation of TH activity in granulocytes. The modulation of EAE in mice with deletion of Nr4a1 and TH driven by Cre expressed via the LysM-Cre transgene, which drives deletion in macrophages and monocytes but not in microglia, indicated that microglia did not have a major role in the Nr4a1-mediated neuroprotective mechanism described here. Notably, circulating CD14 + monocytes isolated from patients with MS had increased TH expression, which further suggested a diseasepromoting role for TH in monocytes and monocyte-derived macrophages. Nevertheless, we cannot exclude the possibility that the lack of patrolling monocytes in Nr4a1 −/− mice 15 might have contribute to their susceptibility to EAE; although this cell type constitutes a relatively small part of the myeloid infiltrate in the CNS, these cells might serve a protective role by maintaining vasculature homeostasis.
Both proinflammatory roles and anti-inflammatory roles for Nr4a1 have been described in various functional settings, including its modulation of the transcription factor NF-κB pathway 49, 50 . Another member of the Nr4a family, Nr4a2, expressed in microglia and astrocytes, has been shown to mediate neuroprotection by recruiting the transrepressor CoREST to the promoters of genes that are targets of NF-κB 51 . However, our data demonstrated an alternative neuroprotective function for Nr4a1 in EAE that entailed suppression of NE production in macrophages through recruitment of the CoRESThistone deacetylase complex to the Th promoter. Notably, reduced expression of Nr4a1 has been found in peripheral blood mononuclear cells of patients with MS before disease onset 52, 53 , which supports the proposal of a protective role for Nr4a1 in MS. Future studies should further assess the role of Nr4a1-mediated regulation of TH in human monocyte subsets and monocyte-derived macrophages in MS.
Published studies have described the necessity of neurologicalimmunological communication in controlling inflammation 3, 54 , yet the molecular mechanisms that regulate this are still unclear. Our work has suggested a pivotal role for TH-producing myeloid cells and for neurological-immunological regulators such as Nr4a1 in controlling CNS inflammation. Our works also opens new avenues for potential MS therapies via manipulation of the amount or activity of Nr4a1 to regulate myeloid adrenergic responses.
METHODS
Methods and any associated references are available in the online version of the paper. Calculations of frequency were based on live cells as determined by forward and side scatter and viability analysis. Mean fluorescence intensity was quantified, and expression was calculated relative to that of the wild-type control. Cellular fluorescence was assessed with an LSR II or FACSAria II (all from BD Biosciences) and data were analyzed with FlowJo software (version 9.8; TreeStar).
Blood-brain barrier-permeability analysis. Vascular permeability was evaluated by measurement of the extravasation of Evans blue dye (EBD). EBD (30 mg per kg body weight, in a volume of 200 µl) was injected intravenously in mice anesthetized with ketamine and xylazine and was allowed to circulate for 30 min. The mice were then euthanized, their chest was opened, the inferior vena cava was transected, and the vasculature was flushed with 20 ml saline via the right ventricle for removal of excess intravascular dye. The brain and spinal cord were homogenized and were incubated for 24 h at 37 °C in 100% formamide for extraction of EBD. The concentration of extracted EBD was analyzed by spectrophotometry. Correction for the absorbance (optical density) of contaminating heme pigments was performed as described 63 Quantitative RT-PCR. RNA was isolated with an RNeasy kit (Qiagen), and cDNA was prepared with an Omniscript RT kit (Qiagen). Quantitative PCR was performed on a Light Cycler (Roche) with RT 2 primers (Qiagen) and SYBR Green dye (Roche). For analysis of genes encoding members of the Nr4a family, we used a Taqman assay (Life Technologies).
Luciferase promoter-reporter assay. For the generation of a TH luciferase reporter, the Th promoter (from position −9 to position −4555 relative to the transcription start site) was cloned into the vector pGL4.10(luc2) (Promega). For the assay, cells were seeded in 12-well plates; after overnight incubation, cells were transfected with 0.5 µg TH luciferase reporter vector and 0.2 µg β-galactosidase reporter vector (pCMVβ; Promega), and with other DNA and small interfering RNA (described above), through the use of a Fugene kit (Promega) for RAW cells or an Amaxa Nucleofector system (Lonza) for BMM. After 24 h, luciferase activity was measured with the Dual-Luciferase Reporter Assay System (Promega).
Co-immunoprecipitation and immunoblot analysis. RAW cells were transfected to express Nr4a1, and samples were collected at 24 h and 48 h after transfection. Nr4a1 was precipitated with anti-Nr4a1 (M-210; Santa-Cruz) and a Dynabeads co-immunoprecipitation kit (Life Technologies), and the samples were analyzed by immunoblot with anti-CoREST (K72/8; Millipore).
Statistical analysis.
Data for all experiments were analyzed with Prism software (GraphPad). Unpaired t-tests and two-way analysis of variance were used for comparison of experimental groups. P values of less than 0.05 were considered significant. The data seemed to be normally distributed, with similar s.d. and error observed between and within experimental groups.
